Harada H - Search Results

1

Donor-derived gene mutations in sex chromosome loss after stem cell transplantation.

Adachi H, Sadato D, Toya T, Hirama C, Haraguchi K, Mukae J, Shingai N, Shimizu H, Najima Y, Kobayashi T, Okuyama Y, Oboki K, Harada H, Sakamaki H, Ohashi K, Harada Y, Doki N. Adachi H, et al. Among authors: harada h, harada y. Br J Haematol. 2021 Nov;195(3):e142-e146. doi: 10.1111/bjh.17716. Epub 2021 Jul 27. Br J Haematol. 2021. PMID: 34312849 No abstract available.

2

Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia.

Harada H, Harada Y, Tanaka H, Kimura A, Inaba T. Harada H, et al. Among authors: harada y. Blood. 2003 Jan 15;101(2):673-80. doi: 10.1182/blood-2002-04-1010. Epub 2002 Sep 5. Blood. 2003. PMID: 12393679 Free article.

3

High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.

Harada H, Harada Y, Niimi H, Kyo T, Kimura A, Inaba T. Harada H, et al. Among authors: harada y. Blood. 2004 Mar 15;103(6):2316-24. doi: 10.1182/blood-2003-09-3074. Epub 2003 Nov 13. Blood. 2004. PMID: 14615365 Free article.

4

Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome.

Harada H, Harada Y. Harada H, et al. Among authors: harada y. Crit Rev Eukaryot Gene Expr. 2005;15(3):183-96. doi: 10.1615/critreveukargeneexpr.v15.i3.10. Crit Rev Eukaryot Gene Expr. 2005. PMID: 16390315 Review.

5

Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS.

Harada H, Harada Y, Kimura A. Harada H, et al. Among authors: harada y. Curr Cancer Drug Targets. 2006 Sep;6(6):553-65. doi: 10.2174/156800906778194595. Curr Cancer Drug Targets. 2006. PMID: 17017876 Review.

6

AML1 mutations induced MDS and MDS/AML in a mouse BMT model.

Watanabe-Okochi N, Kitaura J, Ono R, Harada H, Harada Y, Komeno Y, Nakajima H, Nosaka T, Inaba T, Kitamura T. Watanabe-Okochi N, et al. Among authors: harada h, harada y. Blood. 2008 Apr 15;111(8):4297-308. doi: 10.1182/blood-2007-01-068346. Epub 2008 Jan 11. Blood. 2008. PMID: 18192504 Free article.

7

Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.

Harada Y, Harada H. Harada Y, et al. Among authors: harada h. J Cell Physiol. 2009 Jul;220(1):16-20. doi: 10.1002/jcp.21769. J Cell Physiol. 2009. PMID: 19334039 Review.

8

AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms.

Ding Y, Harada Y, Imagawa J, Kimura A, Harada H. Ding Y, et al. Among authors: harada h, harada y. Blood. 2009 Dec 10;114(25):5201-5. doi: 10.1182/blood-2009-06-223982. Blood. 2009. PMID: 19850737 Free article.

9

[Molecular mechanisms in myeloproliferative diseases and myelodysplastic syndromes].

Harada H, Harada Y, Kimura A. Harada H, et al. Among authors: harada y. Nihon Rinsho. 2009 Oct;67(10):1901-5. Nihon Rinsho. 2009. PMID: 19860187 Review. Japanese.

10

Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia.

Nakahara F, Sakata-Yanagimoto M, Komeno Y, Kato N, Uchida T, Haraguchi K, Kumano K, Harada Y, Harada H, Kitaura J, Ogawa S, Kurokawa M, Kitamura T, Chiba S. Nakahara F, et al. Among authors: harada h, harada y. Blood. 2010 Apr 8;115(14):2872-81. doi: 10.1182/blood-2009-05-222836. Epub 2009 Oct 27. Blood. 2010. PMID: 19861684 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,673 results

Search Page

Filters